Literature DB >> 10891932

Benign cough headache is responsive to acetazolamide.

S J Wang1, J L Fuh, S R Lu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10891932     DOI： 10.1212/wnl.55.1.149

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  8 in total

Review 1.  Focus on therapy of the Chapter IV headaches provoked by exertional factors: primary cough headache, primary exertional headache and primary headache associated with sexual activity.

Authors:  Marta Allena; Paolo Rossi; Cristina Tassorelli; Enrico Ferrante; Carlo Lisotto; Giuseppe Nappi
Journal:  J Headache Pain       Date:  2010-10-02       Impact factor: 7.277

Review 2.  Primary cough headache.

Authors:  Julio Pascual
Journal:  Curr Pain Headache Rep       Date:  2005-08

Review 3.  The "other" headaches: primary cough, exertion, sex, and primary stabbing headaches.

Authors:  Shuu-Jiun Wang; Jong-Ling Fuh
Journal:  Curr Pain Headache Rep       Date:  2010-02

4.  Headache secondary to an unusual Valsalva manoeuvre in a migrainous patient with cacosmia.

Authors:  Ferdinando Maggioni; Claudio Baracchini; Maria Lucia Malvindi; Giorgio Zanchin
Journal:  Neurol Sci       Date:  2011-03-16       Impact factor: 3.307

Review 5.  Indomethacin-responsive headaches.

Authors:  Juliana VanderPluym
Journal:  Curr Neurol Neurosci Rep       Date:  2015       Impact factor: 5.081

6.  Other primary headaches.

Authors:  Anish Bahra
Journal:  Ann Indian Acad Neurol       Date:  2012-08       Impact factor: 1.383

7.  Headaches precipitated by cough, prolonged exercise or sexual activity: a prospective etiological and clinical study.

Authors:  Julio Pascual; Andrés González-Mandly; Rubén Martín; Agustín Oterino
Journal:  J Headache Pain       Date:  2008-08-28       Impact factor: 7.277

Review 8.  Headache associated with cough: a review.

Authors:  Ann Cordenier; Willem De Hertogh; Jacques De Keyser; Jan Versijpt
Journal:  J Headache Pain       Date:  2013-05-20       Impact factor: 7.277
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.